低分子肝素钙治疗不稳定型心绞痛临床疗效探讨

Clinical Effect of Low Molecular Weight Hparin Calcium on Unstable Angina Pectoris

目的:探讨分析低分子肝素钙治疗不稳定型心绞痛临床疗效。方法:从2017年6月~2019年4月于某院治疗的不稳定型心绞痛患者病例中选取100例作为研究对象,随机分为对照组和观察组,对照组采取常规药物治疗,观察组在对照组的基础上采取低分子肝素钙治疗,对两组患者的心绞痛发作情况、心电图检查情况、治疗有效率、不良反应率等进行对比和分析。结果:治疗后,观察组的心绞痛发作次数、持续时间及T波倒置联数等明显低于对照组(P<0.05);观察组的T波倒置深度浅于对照组患者,具有统计学意义(P<0.05);治疗后,观察组的TT、PT及APTP高于对照组(P<0.05);观察组患者总有效率明显高于对照组,具有统计学意义(P<0.05)。结论:在临床治疗不稳定型心绞痛过程中,低分子肝素钙治疗具有显著的疗效。

Objective:To explore the clinical effect of low molecular weight heparin calcium in the treatment of unstable angina pectoris.Methods:100 patients with unstable angina pectoris in a hospital from June 2017 to April 2019 were selected and randomly divided into control group and observation group.The control group was treated with conventional drugs,and the observation group was treated with low molecular weight heparin calcium on the basis of the control group,then the angina attack,electrocardiogram examination,effective rate and adverse reaction rate of the two groups were compared and analyzed.Results:After treatment,the number of angina attacks,duration and T wave inversion in the observation group were significantly lower than those in the control group(P<0.05).The depth of T wave inversion in the observation group was shallower than that in the control group,with statistical significance(P<0.05).After treatment,TT,Pt and APTP in the observation group were higher than those in the control group(P<0.05).The total effective rate in the observation group was significantly higher than that in the control group,with statistical significance(P<0.05).Conclusion:In the clinical treatment of unstable angina pectoris,low molecular weight heparin calcium treatment has a significant effect.